Under pressure: A cohort analysis of elevated intraocular pressure in long-term vascular endothelial growth factor inhibitor treatment

Clin Exp Ophthalmol. 2020 Nov;48(8):1104-1106. doi: 10.1111/ceo.13831. Epub 2020 Aug 23.

Authors

Matthew McCartney^{1

2}, Beverley Curry³, Paul Sanfilippo³, Nitin Verma^{3

4

2}

Affiliations

¹ Department of Ophthalmology, Sydney Eye Hospital, Sydney, New South Wales, Australia.
² School of Medicine, University of Sydney, Camperdown, New South Wales, Australia.
³ Department of Ophthalmology, Hobart Eye Surgeons, Hobart, Tasmania, Australia.
⁴ School of Medicine, University of Tasmania, Hobart, Tasmania, Australia.

PMID: 32770769
DOI: 10.1111/ceo.13831

No abstract available

Publication types

Letter

MeSH terms

Angiogenesis Inhibitors
Bevacizumab
Cohort Studies
Humans
Intraocular Pressure*
Intravitreal Injections
Ranibizumab
Vascular Endothelial Growth Factor A*

Substances

Angiogenesis Inhibitors
Vascular Endothelial Growth Factor A
Bevacizumab
Ranibizumab